Skip to main content
Clinical Trials/ACTRN12611000360910
ACTRN12611000360910
Completed
未知

In critically ill patients who required Continuous Venovenous Hemofiltration (CVVH), what is the effect of using Regional citrate anticoagulation (RCA) on circuit time, rate of correction of patient's metabolic acidosis and any untoward side effect?

Dr Anne Leung0 sites30 target enrollmentApril 7, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Anne Leung
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 7, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Dr Anne Leung

Eligibility Criteria

Inclusion Criteria

  • CVVH with regional citrate anticoagulant that last for more than 4 hours

Exclusion Criteria

  • CVVH not using regional citrate as anticoagulant
  • session of CVVH last less than 4 hours

Outcomes

Primary Outcomes

Not specified

Similar Trials